Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 31-Mar-21 12:30 PM View:  | Urovant Sciences Ltd. (UROV) | 29-Mar-21 | Disposition | 78,781 | -- | -- | (100%) 78.78K to 0 | |
| 04-May-20 4:53 PM View: | Urovant Sciences Ltd. (UROV) | 01-May-20 | Grant | 44,346 | -- | -- | 135% 32.83K to 77.18K | |
| 09-Jan-20 4:32 PM View: | Urovant Sciences Ltd. (UROV) | 07-Jan-20 | Grant | 32,833 | -- | -- | 100% 0 to 32.83K | |
| 11-May-17 8:30 PM View: | Eledon Pharmaceuticals, Inc. (NVUS) | 10-May-17 | Purchase | 10,010 | $9.99 | $99,999.90 | 86% 11.58K to 21.59K | |
| 18-Dec-14 8:55 PM View: | Avanir Pharmaceuticals (AVNR) | 18-Dec-14 | Market Sale (Planned) | 5,780 | $16.93 | $97,855.40 | (5%) 114.58K to 108.8K | < 1% |
| 18-Dec-14 8:55 PM View: | Avanir Pharmaceuticals (AVNR) | 16-Dec-14 | Option Exercise | 30,000 | $3.52 | $105,525.00 | 26% 114.58K to 144.58K | |
| 18-Dec-14 8:55 PM View: | Avanir Pharmaceuticals (AVNR) | 16-Dec-14 | Market Option Sale (Planned) | 30,000 | $16.94 | $508,200.00 | (21%) 144.58K to 114.58K | < 1% |
| 12-Nov-14 10:00 PM View: | Avanir Pharmaceuticals (AVNR) | 10-Nov-14 | Grant | 51,836 | -- | -- | 83% 62.74K to 114.58K | |
| 24-Oct-14 8:22 PM View: | Avanir Pharmaceuticals (AVNR) | 24-Oct-14 | Market Sale (Planned) | 2,080 | $11.81 | $24,564.80 | (3%) 79.87K to 77.79K | (< 1%) |
| 17-Sep-14 8:44 PM View: | Avanir Pharmaceuticals (AVNR) | 15-Sep-14 | Market Sale (Planned) | 55,000 | $9.45 | $519,750.00 | (41%) 134.87K to 79.87K | (21%) |
| 28-Aug-14 9:03 PM View: | Avanir Pharmaceuticals (AVNR) | 26-Aug-14 | Market Sale (Planned) | 2,110 | $6.10 | $12,871.00 | (3%) 81.98K to 79.87K | (87%) |
| 16-May-14 8:00 PM View: | Avanir Pharmaceuticals (AVNR) | 16-May-14 | Market Sale | 11,900 | $4.88 | $58,072.00 | (12%) 96.88K to 84.98K | (133%) |
| 16-May-14 8:00 PM View: | Avanir Pharmaceuticals (AVNR) | 14-May-14 | Market Sale | 25,596 | $5.13 | $131,307.00 | (21%) 122.48K to 96.88K | (122%) |
| 14-Feb-14 7:56 PM View: | Avanir Pharmaceuticals (AVNR) | 12-Feb-14 | Grant | 44,375 | -- | -- | 57% 78.1K to 122.48K | |
| 20-Dec-13 5:26 PM View: | Avanir Pharmaceuticals (AVNR) | 18-Dec-13 | Market Sale (Planned) | 2,450 | $2.63 | $6,445.46 | (3%) 80.55K to 78.1K | (333%) |
| 17-May-13 8:01 PM View: | Avanir Pharmaceuticals (AVNR) | 15-May-13 | Option Exercise | 57,700 | $0.88 | $50,776.00 | 57% 100.55K to 158.25K | |
| 17-May-13 8:01 PM View: | Avanir Pharmaceuticals (AVNR) | 15-May-13 | Market Option Sale (Planned) | 57,700 | $3.29 | $189,548.00 | (36%) 158.25K to 100.55K | (247%) |
| 17-May-13 8:01 PM View: | Avanir Pharmaceuticals (AVNR) | 15-May-13 | Market Sale (Planned) | 20,000 | $3.29 | $65,701.30 | (20%) 100.55K to 80.55K | (247%) |
| 19-Dec-12 4:43 PM View: | Avanir Pharmaceuticals (AVNR) | 17-Dec-12 | Grant | 30,251 | -- | -- | 43% 70.3K to 100.55K | |
| 05-Dec-12 4:40 PM View: | Avanir Pharmaceuticals (AVNR) | 03-Dec-12 | Market Sale (Planned) | 2,845 | $2.55 | $7,257.60 | (4%) 73.15K to 70.3K | (346%) |
| 19-Sep-12 4:31 PM View: | Avanir Pharmaceuticals (AVNR) | 17-Sep-12 | Option Exercise | 65,000 | $0.53 | $34,450.00 | 89% 73.15K to 138.15K | |
| 19-Sep-12 4:31 PM View: | Avanir Pharmaceuticals (AVNR) | 17-Sep-12 | Market Option Sale (Planned) | 65,000 | $3.49 | $226,824.00 | (47%) 138.15K to 73.15K | (226%) |
| 07-Mar-12 9:02 AM View: | Avanir Pharmaceuticals (AVNR) | 06-Mar-12 | Market Purchase | 3,000 | $2.60 | $7,794.90 | 4% 70.15K to 73.15K | 334% |
| 16-Dec-11 8:38 PM View: | Avanir Pharmaceuticals (AVNR) | 15-Dec-11 | Grant | 20,000 | -- | -- | 40% 50.15K to 70.15K | |
| 06-Dec-11 5:00 PM View: | Avanir Pharmaceuticals (AVNR) | 02-Dec-11 | Market Sale (Planned) | 2,676 | $2.38 | $6,371.82 | (5%) 52.82K to 50.15K | (376%) |
| 14-Nov-11 5:11 PM View: | Avanir Pharmaceuticals (AVNR) | 11-Nov-11 | Option Exercise | 92,250 | $0.89 | $82,380.00 | 175% 52.82K to 145.07K | |
| 14-Nov-11 5:11 PM View: | Avanir Pharmaceuticals (AVNR) | 11-Nov-11 | Market Option Sale (Planned) | 92,250 | $2.62 | $242,055.00 | (64%) 145.07K to 52.82K | (332%) |
| 18-Feb-11 1:38 PM View: | Avanir Pharmaceuticals (AVNR) | 17-Feb-11 | txn.W.title | 1,350 | -- | -- | 3% 51.47K to 52.82K | |
| 08-Dec-10 12:38 PM View: | Avanir Pharmaceuticals (AVNR) | 06-Dec-10 | Market Sale (Planned) | 13,660 | $3.79 | $51,771.40 | (21%) 65.13K to 51.47K | (194%) |
| 03-Dec-10 8:59 PM View: | Avanir Pharmaceuticals (AVNR) | 03-Dec-10 | Option Exercise | 23,350 | $1.41 | $32,889.00 | 36% 65.13K to 88.48K | |
| 03-Dec-10 8:59 PM View: | Avanir Pharmaceuticals (AVNR) | 03-Dec-10 | Market Option Sale | 23,350 | $4.03 | $94,100.50 | (26%) 88.48K to 65.13K | (176%) |
| 03-Dec-10 8:59 PM View: | Avanir Pharmaceuticals (AVNR) | 02-Dec-10 | Option Exercise | 24,000 | $1.74 | $41,760.00 | 37% 65.13K to 89.13K | |
| 03-Dec-10 8:59 PM View: | Avanir Pharmaceuticals (AVNR) | 02-Dec-10 | Market Option Sale | 24,000 | $4.15 | $99,600.00 | (27%) 89.13K to 65.13K | (168%) |
| 03-Dec-10 8:59 PM View: | Avanir Pharmaceuticals (AVNR) | 01-Dec-10 | Grant | 11,250 | -- | -- | 21% 53.88K to 65.13K | |
| 13-Aug-10 6:27 PM View: | Avanir Pharmaceuticals (AVNR) | 11-Aug-10 | Option Exercise | 28,250 | $1.06 | $30,060.00 | 52% 53.88K to 82.13K | |
| 13-Aug-10 6:27 PM View: | Avanir Pharmaceuticals (AVNR) | 11-Aug-10 | Market Option Sale | 28,250 | $3.11 | $87,731.70 | (34%) 82.13K to 53.88K | (258%) |
| 17-Mar-10 6:00 PM View: | Avanir Pharmaceuticals (AVNR) | 16-Mar-10 | Market Sale (Planned) | 15,518 | $2.08 | $32,283.10 | (22%) 69.4K to 53.88K | (435%) |
| 25-Feb-09 3:24 PM View: | Avanir Pharmaceuticals (AVNR) | 24-Feb-09 | Market Purchase | 11,900 | $0.44 | $5,216.00 | 21% 57.5K to 69.4K | 2528% |
| 19-May-05 5:29 PM View: | Cardiogenesis Corporation (CGCP) | 19-May-05 | Market Purchase | 20,000 | $0.44 | $8,700.00 | 100% 0 to 20.0K | (39%) |